• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Stocks That Hit 52-Week Lows On Wednesday

    8/30/23 1:18:58 PM ET
    $AKTS
    $ATXI
    $AULT
    $AWIN
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AKTS alert in real time by email

     

    On Wednesday, 59 companies achieved new lows for the year.

    Interesting Points From Today's 52-Week Lows:

    • The largest company by market cap to set a new 52-week low was Dollar Tree (NASDAQ:DLTR).
    • The company with the smallest market cap to set a new 52-week low was SenesTech (NASDAQ:SNES).
    • Outlook Therapeutics (NASDAQ:OTLK)'s stock fell the most, as it traded down 84.34% to reach a new 52-week low.
    • Dollar Tree (NASDAQ:DLTR)'s shares had the biggest turnaround, impressively rebounding 0.05% after reaching a new 52-week low.

    Here are all the stocks that set new 52-week lows on Wednesday:

    • Dollar Tree (NASDAQ:DLTR) shares moved up 0.05% on Wednesday to hit a new 52-week low of $122.00, drifting up 0.05%.
    • Hain Celestial Group (NASDAQ:HAIN) shares made a new 52-week low of $10.93 on Wednesday. The stock was up 0.32% for the day.
    • SIGNA Sports United (NYSE:SSU) shares set a new yearly low of $1.23 this morning. The stock was down 6.06% on the session.
    • Ioneer (NASDAQ:IONR) shares hit a yearly low of $6.21. The stock was down 2.59% on the session.
    • Vanda Pharma (NASDAQ:VNDA) stock hit a yearly low of $5.26. The stock was down 3.83% for the day.
    • noco-noco (NASDAQ:NCNC) stock hit a new 52-week low of $1.62. The stock was down 13.05% on the session.
    • Karyopharm Therapeutics (NASDAQ:KPTI) stock hit a new 52-week low of $1.33. The stock was up 1.84% on the session.
    • Satellogic (NASDAQ:SATL) stock set a new 52-week low of $1.51 on Wednesday, moving up 1.97%.
    • Faraday Future (NASDAQ:FFIE) shares were down 12.68% for the day, having made a 52-week low of $7.18.
    • Radcom (NASDAQ:RDCM) stock set a new 52-week low of $8.56 on Wednesday, moving up 1.24%.
    • Hawthorn Bancshares (NASDAQ:HWBK) shares were down 0.71% for the day, having made a 52-week low of $16.50.
    • Akoustis Technologies (NASDAQ:AKTS) shares hit a yearly low of $1.53. The stock was down 0.93% on the session.
    • Electrovaya (NASDAQ:ELVA) shares set a new yearly low of $3.18 this morning. The stock was down 3.32% on the session.
    • Complete Solaria (NASDAQ:CSLR) stock drifted down 5.6% on Wednesday morning to hit a new 52-week low of $2.13.
    • Outlook Therapeutics (NASDAQ:OTLK) shares made a new 52-week low of $0.21 on Wednesday. The stock was down 84.34% for the day.
    • Marketwise (NASDAQ:MKTW) shares set a new yearly low of $1.24 this morning. The stock was up 0.78% on the session.
    • SEALSQ (NASDAQ:LAES) shares set a new 52-week low of $5.00. The stock traded down 14.67%.
    • BYND Cannasoft Enterprise (NASDAQ:BCAN) shares made a new 52-week low of $0.85 on Wednesday. The stock was up 1.38% for the day.
    • Kentucky First Federal (NASDAQ:KFFB) stock dropped to a yearly low on Wednesday of $5.21. Shares traded down 4.58%.
    • TD Hldgs (NASDAQ:GLG) stock set a new 52-week low of $0.20 on Wednesday, moving down 28.45%.
    • Electra Battery Materials (NASDAQ:ELBM) shares set a new 52-week low of $0.65. The stock traded up 0.59%.
    • 22nd Century Group (NASDAQ:XXII) stock hit $1.56 on Wednesday morning, setting a new 52-week low for a change of down 4.71%.
    • USD Partners (NYSE:USDP) shares fell to $0.64 on Wednesday, setting a new 52-week low with a shift of down 1.99%.
    • Fusion Fuel Green (NASDAQ:HTOO) stock broke to a new 52-week low of $1.42 on Wednesday. Shares of the company traded down 16.09%.
    • BM Technologies (AMEX:BMTX) shares hit a yearly low of $1.62. The stock was up 0.61% on the session.
    • AERWINS Technologies (NASDAQ:AWIN) shares fell to $0.19 on Wednesday, setting a new 52-week low with a shift of down 0.9%.
    • Lightning eMotors (NYSE:ZEV) stock hit $1.93 on Wednesday morning, setting a new 52-week low for a change of down 1.05%.
    • Alkaline Water Co (NASDAQ:WTER) shares set a new yearly low of $0.86 this morning. The stock was down 0.13% on the session.
    • Pulmatrix (NASDAQ:PULM) stock hit a new 52-week low of $2.33. The stock was up 2.76% on the session.
    • Avalon Holdings (AMEX:AWX) shares hit a yearly low of $2.16. The stock was down 3.94% on the session.
    • Innovative Eyewear (NASDAQ:LUCY) shares hit a yearly low of $0.58. The stock was down 2.3% on the session.
    • Jaguar Health (NASDAQ:JAGX) shares fell to $0.38 on Wednesday, setting a new 52-week low with a shift of down 0.26%.
    • Avenue Therapeutics (NASDAQ:ATXI) stock drifted down 5.42% on Wednesday morning to hit a new 52-week low of $0.80.
    • Medigus (NASDAQ:MDGS) shares made a new 52-week low of $3.70 on Wednesday. The stock was up 1.41% for the day.
    • Ault Alliance (AMEX:AULT) stock achieved a new 52-week low on Wednesday morning, hitting $1.03 and moving up 0.13%.
    • Ontrak (NASDAQ:OTRK) shares were down 3.54% for the day, having made a 52-week low of $1.04.
    • Biolase (NASDAQ:BIOL) stock hit $4.35 on Wednesday morning, setting a new 52-week low for a change of down 1.97%.
    • Jeffs Brands (NASDAQ:JFBR) stock broke to a new 52-week low of $0.48 on Wednesday. Shares of the company traded down 1.98%.
    • Hallmark Financial Servs (NASDAQ:HALL) stock hit a new 52-week low of $1.95. The stock was up 1.37% on the session.
    • 1847 Holdings (AMEX:EFSH) stock drifted up 0.15% on Wednesday morning to hit a new 52-week low of $0.09.
    • Shineco (NASDAQ:SISI) shares were down 6.78% for the day, having made a 52-week low of $0.13.
    • SenesTech (NASDAQ:SNES) shares moved down 5.09% on Wednesday to hit a new 52-week low of $0.55, drifting down 5.09%.

    Be sure to stay with Benzinga for further updates and market-moving news. And if you want to be among the first to know about the 52-week highs and lows for the day, check out Benzinga Pro. Users receive a daily alert listing stocks trading near 52-week highs and lows each morning. Click here to learn more.

    Get the next $AKTS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AKTS
    $ATXI
    $AULT
    $AWIN

    CompanyDatePrice TargetRatingAnalyst
    Karyopharm Therapeutics Inc.
    $KPTI
    3/10/2026$28.00Buy
    Rodman & Renshaw
    Aktis Oncology Inc.
    $AKTS
    3/9/2026$30.00Buy
    H.C. Wainwright
    Vanda Pharmaceuticals Inc.
    $VNDA
    3/5/2026$18.00Buy
    Truist
    Dollar Tree Inc.
    $DLTR
    2/27/2026$132.00Buy → Neutral
    Citigroup
    Satellogic Inc.
    $SATL
    2/20/2026$7.00Overweight
    Cantor Fitzgerald
    Satellogic Inc.
    $SATL
    2/18/2026$5.50Outperform
    Northland Capital
    Dollar Tree Inc.
    $DLTR
    2/17/2026$165.00Neutral → Buy
    Rothschild & Co Redburn
    Dollar Tree Inc.
    $DLTR
    2/13/2026$95.00Market Perform → Underperform
    BMO Capital Markets
    More analyst ratings

    $AKTS
    $ATXI
    $AULT
    $AWIN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Rodman & Renshaw initiated coverage on Karyopharm Therapeutics with a new price target

    Rodman & Renshaw initiated coverage of Karyopharm Therapeutics with a rating of Buy and set a new price target of $28.00

    3/10/26 8:41:07 AM ET
    $KPTI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    H.C. Wainwright initiated coverage on Aktis Oncology with a new price target

    H.C. Wainwright initiated coverage of Aktis Oncology with a rating of Buy and set a new price target of $30.00

    3/9/26 9:06:39 AM ET
    $AKTS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Truist initiated coverage on Vanda Pharma with a new price target

    Truist initiated coverage of Vanda Pharma with a rating of Buy and set a new price target of $18.00

    3/5/26 8:32:16 AM ET
    $VNDA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AKTS
    $ATXI
    $AULT
    $AWIN
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    June 18, 2024 - FDA Roundup: June 18, 2024

    For Immediate Release: June 18, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA announced a request for input about patient safety associated with certain medical software functions excluded from the medical device definition. This input will help the FDA develop the 2024 report on the risks and benefits to health of non-devic

    6/18/24 3:16:28 PM ET
    $DLTR
    $AMGN
    Department/Specialty Retail Stores
    Consumer Discretionary
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    FDA Approval for PONVORY issued to VANDA PHARMS INC

    Submission status for VANDA PHARMS INC's drug PONVORY (SUPPL-6) with active ingredient PONESIMOD has changed to 'Approval' on 06/05/2024. Application Category: NDA, Application Number: 213498, Application Classification: Labeling

    6/17/24 12:07:18 AM ET
    $VNDA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for PONVORY issued to VANDA PHARMS INC

    Submission status for VANDA PHARMS INC's drug PONVORY (SUPPL-5) with active ingredient PONESIMOD has changed to 'Approval' on 06/05/2024. Application Category: NDA, Application Number: 213498, Application Classification: Labeling

    6/17/24 12:07:18 AM ET
    $VNDA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AKTS
    $ATXI
    $AULT
    $AWIN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Mickels Erik sold $148,867 worth of shares (10,000 units at $14.89), decreasing direct ownership by 15% to 56,437 units (SEC Form 4)

    4 - MARKETWISE, INC. (0001805651) (Issuer)

    3/12/26 4:36:41 PM ET
    $MKTW
    Computer Software: Prepackaged Software
    Technology

    Director Micek John was granted 7,377 shares, increasing direct ownership by 13,919% to 7,430 units (SEC Form 4)

    4 - Jaguar Health, Inc. (0001585608) (Issuer)

    3/12/26 3:03:56 PM ET
    $JAGX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SVP & General Counsel Williams Timothy sold $350,755 worth of shares (42,434 units at $8.27), decreasing direct ownership by 10% to 377,450 units (SEC Form 4)

    4 - Vanda Pharmaceuticals Inc. (0001347178) (Issuer)

    3/4/26 6:54:11 PM ET
    $VNDA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AKTS
    $ATXI
    $AULT
    $AWIN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing

    NEW YORK, March 13, 2026 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced that presentations from the Life Sciences Virtual Investor Forum, held March 11th – 12th, are now available for on-demand viewing. The forum featured CEO chats and company presentations from leadership teams representing innovative companies across the biotechnology, medical device, and pharmaceutical sectors, offering investors insights into emerging technologies, strategic initiatives, and growth opportunities within the life sciences industry. REGISTER AND VIEW PRESENTATIONS HERE The presentations will be available 24/7 for 90 days. Investors,

    3/13/26 8:35:00 AM ET
    $AEMD
    $CVKD
    $DYAI
    Medical/Dental Instruments
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Biotechnology: Biological Products (No Diagnostic Substances)

    SEALSQ and Parrot Expand Their Strategic Partnership: Parrot to Integrate SEALSQ Post-Quantum Cryptography into Its Next Generation of Secure Drones

    Paris, France / Geneva, Switzerland , March 13, 2026 (GLOBE NEWSWIRE) -- Parrot CEO & founder Henri Seydoux together with SEALSQ General Manager Bernard Vian and EMEA Sales Director Fabien Treillaud at Embedded World, Nuremberg, on March 11, 2026. SEALSQ Corp (NASDAQ:LAES) ("SEALSQ" or the "Company"), a global leader in post-quantum semiconductor security, and Parrot SA, Europe's leading commercial micro-UAV group, today announced the expansion of their long-standing strategic collaboration to integrate Post-Quantum Cryptography (PQC) technologies from SEALSQ into Parrot's next generation of professional drones. A Partnership Built on Proven Security Excellence Parrot and SEALSQ ha

    3/13/26 8:00:00 AM ET
    $LAES
    Semiconductors
    Technology

    SenesTech Announces 2025 Financial Results Driven by Strong Growth in E-Commerce

    SURPRISE, Ariz., March 12, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES), a leader in birth control solutions for managing rodent populations, today announced financial results for the fourth quarter and the full year ended December 31, 2025. 2025 HighlightsRevenue increased by 20% to $2.2 million in 2025 as compared to 2024, driven by strong growth in the Company's overall e-commerce channels despite the impact associated with the Company's transition to directly managing Amazon sales of Evolve® Rat and Evolve Mouse. Excluding this transition-related impact, we estimate re

    3/12/26 4:05:00 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    $AKTS
    $ATXI
    $AULT
    $AWIN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Glenbrook Capital Management bought $200,635 worth of shares (85,901 units at $2.34) (SEC Form 4)

    4 - SenesTech, Inc. (0001680378) (Issuer)

    2/19/26 7:57:41 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    Large owner Glenbrook Capital Management bought $56,667 worth of shares (31,346 units at $1.81) (SEC Form 4)

    4 - SenesTech, Inc. (0001680378) (Issuer)

    2/13/26 5:20:17 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    Large owner Glenbrook Capital Management bought $15,480 worth of shares (8,569 units at $1.81) (SEC Form 4)

    4 - SenesTech, Inc. (0001680378) (Issuer)

    2/6/26 5:40:20 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    $AKTS
    $ATXI
    $AULT
    $AWIN
    SEC Filings

    View All

    SEC Form 6-K filed by Jeffs' Brands Ltd

    6-K - Jeffs' Brands Ltd (0001885408) (Filer)

    3/13/26 4:01:07 PM ET
    $JFBR
    Other Specialty Stores
    Consumer Discretionary

    SenesTech Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - SenesTech, Inc. (0001680378) (Filer)

    3/12/26 4:06:15 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    SEC Form 6-K filed by Jeffs' Brands Ltd

    6-K - Jeffs' Brands Ltd (0001885408) (Filer)

    3/12/26 9:29:53 AM ET
    $JFBR
    Other Specialty Stores
    Consumer Discretionary

    $AKTS
    $ATXI
    $AULT
    $AWIN
    Leadership Updates

    Live Leadership Updates

    View All

    Tim Johnson Nominated to Join Amaero Board

    MCDONALD, Tenn., March 10, 2026 (GLOBE NEWSWIRE) -- Amaero Ltd (ASX:3DA) (OTC:AMROF) ("Amaero" or the "Company"), a leading U.S. domestic producer of high-value refractory and titanium alloy powders for additive and advanced manufacturing of components utilized by the defense, space, and aviation industries, is pleased to announce that Tim "TJ" Johnson has been nominated to join Amaero's Board as a Non-Executive Director, subject to satisfying the requisite regulatory requirements. Upon joining the Board as a Non-Executive Director, it is anticipated that he will assume the responsibilities of Chairman of the Audit and Risk Committee. Mr. Johnson is an experienced corporate board member

    3/10/26 8:00:00 AM ET
    $DLTR
    $DRVN
    $EAT
    Department/Specialty Retail Stores
    Consumer Discretionary
    Automotive Aftermarket
    Restaurants

    WISeKey Appoints Gwenael Rouy-Poirier as Chief Financial Officer of WISeSat, its Satellite Connectivity Subsidiary

    WISeKey Appoints Gwenael Rouy-Poirier as Chief Financial Officer of WISeSat, its Satellite Connectivity Subsidiary Geneva, Switzerland, February 10, 2026 – WISeKey International Holding Ltd ("WISeKey" or the "Company") ((SIX: WIHN, NASDAQ:WKEY), a global leader in cybersecurity, digital identity and Internet of Things (IoT) solutions, today announced the appointment of Gwenael Rouy-Poirier as Chief Financial Officer of its subsidiary WISeSat.Space Corp. ("WISeSat") specialized in space-technology and secure satellite communications for IoT applications, effective February 2, 2026. Of note, in November 2025, WISeSat announced a Business Combination Agreement with Columbus Acquisition Corp.

    2/10/26 1:00:00 AM ET
    $CODA
    $COLA
    $LAES
    Industrial Machinery/Components
    Industrials
    Semiconductors
    Technology

    SenesTech Announces CEO Transition Plan

    Board To Initiate Search For New Leadership As Current CEO Plans Retirement Dr. Jamie Bechtel Named Interim Executive Chair To Further Support Transition PHOENIX, Jan. 28, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES), a pioneer in fertility control solutions for managing rodent populations, today announced that Joel Fruendt, President and Chief Executive Officer, has informed the Board of Directors of his intent to retire. The Board will commence a formal search for a successor. Mr. Fruendt will continue to serve as President and CEO until the search is completed or until June 30, 2026, whichever occurs first.

    1/28/26 4:05:00 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    $AKTS
    $ATXI
    $AULT
    $AWIN
    Financials

    Live finance-specific insights

    View All

    SenesTech Announces 2025 Financial Results Driven by Strong Growth in E-Commerce

    SURPRISE, Ariz., March 12, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES), a leader in birth control solutions for managing rodent populations, today announced financial results for the fourth quarter and the full year ended December 31, 2025. 2025 HighlightsRevenue increased by 20% to $2.2 million in 2025 as compared to 2024, driven by strong growth in the Company's overall e-commerce channels despite the impact associated with the Company's transition to directly managing Amazon sales of Evolve® Rat and Evolve Mouse. Excluding this transition-related impact, we estimate re

    3/12/26 4:05:00 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    Innovative Eyewear, Inc. Announces Q4 and Full Year 2025 Earnings Conference Call

    MIAMI, March 10, 2026 /PRNewswire/ -- Innovative Eyewear, Inc. ("Innovative Eyewear" or the "Company") (NASDAQ: LUCY; LUCYW), the developer & manufacturer of smart eyewear under the Lucyd®, Lucyd Armor®, Reebok®, Nautica®, and Eddie Bauer® brands, today announced its upcoming earnings conference call to share the Company's key operational and financial results for the fiscal year ended December 31, 2025. Earnings Call DetailsDate: Tuesday, March 31, 2026Time: 12:00 PM ETParticipant Listening OptionsInterested participants can join the event by using the dial-in numbers, or by cl

    3/10/26 4:30:00 PM ET
    $LUCY
    Ophthalmic Goods
    Health Care

    SenesTech to Report Fourth Quarter and Fiscal Year 2025 Financial Results on Thursday, March 12, 2026

    Financial results to be released after market close; Conference call to be conducted at 5:00 p.m. Eastern timePHOENIX, March 9, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES), a leader in birth control solutions for managing rodent populations, will report financial results for its fourth quarter and fiscal year 2025, ended December 31, 2025, after the market close on Thursday, March 12, 2026. The Company has scheduled a conference call that same day, Thursday, March 12, 2026, at 5:00 pm ET, to review the results. Fourth Quarter and Fiscal Year 2024 Conference Call DetailsDa

    3/9/26 4:15:00 PM ET
    $SNES
    Agricultural Chemicals
    Industrials

    $AKTS
    $ATXI
    $AULT
    $AWIN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Fusion Fuel Green PLC

    SC 13G/A - Fusion Fuel Green PLC (0001819794) (Subject)

    12/11/24 4:02:05 PM ET
    $HTOO
    Industrial Machinery/Components
    Energy

    SEC Form SC 13D filed by Fusion Fuel Green PLC

    SC 13D - Fusion Fuel Green PLC (0001819794) (Filed by)

    12/6/24 6:06:39 PM ET
    $HTOO
    Industrial Machinery/Components
    Energy

    SEC Form SC 13G filed by Fusion Fuel Green PLC

    SC 13G - Fusion Fuel Green PLC (0001819794) (Subject)

    12/3/24 4:00:02 PM ET
    $HTOO
    Industrial Machinery/Components
    Energy